The British medtech company Brainomix has announced that it has closed a series B funding round with a total investment of approximately £16 million.
The previous investors Parkwalk, Boehringer Ingelheim Venture Fund (BIVF) and Oxford University Innovation Fund (OUIF), who are participating again in this round, have been joined by Tencent Holdings.
WHY IT MATTERS
Brainomix recently took the ...
Berlin-based Lindera will use the €6 million funding to help secure international growth and expand its use of artificial intelligence in the healthcare sector.
WHY IT MATTERS
Studies show that the Lindera SturzApp sustainably reduces the risk of falls by up to 20% in older populations and creates time and resource for care-giving staff.
The app is currently in use in more than 350 care...
Israel-based Sheba Medical Centre and the Swedish Karolinska University Hospital will work together in digital health, with the aim of bridging the gap between healthcare, research and innovation.
WHY IT MATTERS
Developing strategic partnerships between international hospitals is seen as a key area in order to combine knowledge and skill in bringing new solutions in digital healthcare that will...
AI-enabled imaging company Aidoc is partnering with ScreenPoint Medical, the maker of an AI product for 2D and 3D mammography.
The collaboration will allow Aidoc to integrate ScreenPoint’s tech into its platform, which Aidoc positioned as the “natural next step” in providing a practice-wide radiology tool.
ScreenPoint’s algorithm assists radiologists in assessing 2D and 3D mammograms. This, the...
Device-maker SPR Therapeutics raised $37 million in a Series D funding round led by Revelation Partners with participation from River Cities Capital and Mutual Capital Partners.
SPR plans to use the cash to speed the commercial use of its pain-relief device, the SPRINT Peripheral Nerve Stimulation System, fund clinical studies and invest in new technology.
“This additional funding will allow us...
PathAI, maker of AI-enabled pathology products, announced Friday it was partnering with pharma and diagnostics giant Roche.
The strategic partnership will allow PathAI to develop and distribute its AI pathology tech through Roche’s uPath enterprise software, a workflow platform for labs.
The collaboration will begin with distributing PathAI’s research-use-only algorithms through the cloud...
Israel-based DreaMed scored another FDA clearance, expanding the availability of its AI-supported diabetes care platform to Type 2 patients.
The Advisor Pro Al Clinical Decision Support System helps healthcare providers manage the insulin needs of patients who use insulin pumps or injections and monitor their glucose levels using a continuous glucose monitor and/or blood glucose meters.
The...
Period-tracking app Flo closed a $50 million Series B financing round, bringing the company’s valuation to $800 million.
The round was led by VNV Global and Target Global. London-based Flo said the latest round brings its total raise to $65 million.
Flo said it will use the capital to improve personalization and give users more advanced insights into their cycles and symptoms. The company also...
.jpeg?itok=HF3iI7dj "Person answering their front door and getting a delivery from another person")
_8_19.jpeg?itok=OBxO5YPE "A piggy bank next to coins and a stethoscope")
